Search

Search Constraints

You searched for: Author/Creator Ohno, Shinji

Search Results

1. A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study. (18th July 2018)

2. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021)

3. Anxiety and related factors among parents of patients with breast cancer after surgery in Japan: A multi‐informant and multilevel study. Issue 1 (2nd September 2021)

5. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Issue 1 (27th February 2019)

6. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Issue 1 (December 2016)

9. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast. (3rd March 2022)

10. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast. (March 2022)